The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

TESARO Inc

Nasdaq: TSRO
Last

(U.S.) $43.81

Today's change+0.48 +1.11%
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.
 

TESARO Inc

Nasdaq: TSRO
Last

(U.S.) $43.81

Today's change+0.48 +1.11%
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.

TESARO Inc crosses above 125-day moving average

TESARO Inc closed up Friday by (U.S.)$0.48 or 1.11% to (U.S.)$43.81 and crossing above its 125-day moving average. Over the last five days, shares have gained 1.62%, but are down 16.27% for the last year to date. Shares have underperformed the S&P 500 by 23.78% during the last year.

Key company metrics

  • Open(U.S.) $43.45
  • Previous close(U.S.) $43.33
  • High(U.S.) $45.13
  • Low(U.S.) $43.24
  • Bid / Ask(U.S.) $20.00 / (U.S.) $0.00
  • YTD % change-16.27%
  • Volume457,892
  • Average volume (10-day)465,804
  • Average volume (1-month)490,371
  • Average volume (3-month)600,662
  • 52-week range(U.S.) $29.51 to (U.S.) $66.95
  • Beta1.76
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$7.28
Updated May 27 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-47,062.34%

TESARO Inc has a net profit margin of -47,062.34%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.02%Sector:HealthcareIndustry:Biotechnology

Latest Company News

  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2016Q4/2015Q3/2015Q2/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedMar 31, 201603/31/2016Dec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit00----
Total cost of revenue10----
Total operating expense87726357
Selling / general / administrative30282317
Research & development53434039
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)4101
Other operating expenses, total--------
Operating income-87-72-63-57
Interest income (expense), net non-operating-4-4-4-4
Gain (loss) on sale of assets--------
Other--------
Income before tax-91-76-67-61
Income after tax-91-76-67-61
Income tax, total--------
Net income-91-76-67-61
Total adjustments to net income--------
Net income before extra. items-91-76-67-61
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-91-76-67-61
Inc. avail. to common incl. extra. items-91-76-67-61
Diluted net income-91-76-67-61
Dilution adjustment--------
Diluted weighted average shares41404040
Diluted EPS excluding extraordinary itemsvalue per share-2.22-1.89-1.66-1.51
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-2.12-1.86-1.66-1.49
R